NEWTON, Mass.--(BUSINESS WIRE)--PGxHealth®, a division of Clinical Data, Inc. (NASDAQ: CLDA), today announced the launch of its new genetic test for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), an inherited and often fatal heart condition, at the 2008 American Heart Association meeting. The addition of the FAMILION® ARVC Test expands the Company’s FAMILION family of genetic tests for inherited cardiac syndromes and marks its third successful test launch in the past 12 months. Clinical Data also announced plans to make its databases of genetic mutations associated with inherited cardiac conditions, such as ARVC, available to the public.
